Gluskin Sheff & Assoc Inc Hepion Pharmaceuticals, Inc. Transaction History

Gluskin Sheff & Assoc Inc

  • $814 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$1.56 - $2.26 $62,400 - $90,399
-40,000 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$1.77 - $2.98 $35,400 - $59,600
20,000 Added 100.0%
40,000 $74,000
Q4 2020

Feb 16, 2021
BUY
$1.58 - $3.64 $31,600 - $72,800
20,000 New
20,000 $44,000

About Hepion Pharmaceuticals, Inc.

HEPA Quotes by TradingView
  • Ticker HEPA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,229,600
  • Market Cap $49.5M
  • Description
  • Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...
More about HEPA
Track This Portfolio

Track Gluskin Sheff & Assoc Inc Portfolio

Follow Gluskin Sheff & Assoc Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gluskin Sheff & Assoc Inc, based on Form 13F filings with the SEC.

News

Stay updated on Gluskin Sheff & Assoc Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email